
Kos Biotechnology Partners Raises $123 Million for Life Sciences Fund
With $123 million in total commitments, Kos Biotechnology Partners has finalized the third closing of its inaugural fund, marking the largest venture capital launch in Greek history. The firm, operating out of New York and Athens, aims to bridge the gap between American drug development expertise and European scientific talent.
























